May 17 (Reuters) - Poxel SA POXEL.PA :
* POXEL REPORTS CASH AND REVENUE FOR Q1 2023 AND PROVIDES
CORPORATE UPDATE
* AS OF MARCH 31, 2023, CASH AND CASH EQUIVALENTS WERE EUR
10.6
MILLION
* TWYMEEG SALES IN JAPAN FOR SUMITOMO PHARMA FISCAL YEAR
20221
EXCEEDED GUIDANCE BY MORE THAN 20%, AND TWYMEEG'S FY 2023
FORECAST FROM SUMITOMO PHARMA WOULD REPRESENT A 90% INCREASE
OVER PRIOR YEAR SALES
* POXEL REPORTED EUR 449 THOUSAND REVENUE FOR QUARTER ENDED
MARCH
31, 2023
Source text for Eikon: ID:nBw3JXlcla
Further company coverage: POXEL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))